Wife convicted of poisoning husband with nicotine in South Korea

Aug.29.2022
Wife convicted of poisoning husband with nicotine in South Korea
A Korean man died from nicotine poisoning, and his wife was suspected of intentionally feeding him the substance.

On a morning in May 2021, a Korean man named A unexpectedly passed away in his home at approximately 7 a.m. After conducting an autopsy, it was determined that the cause of death was nicotine poisoning. As a result, A's wife, B, was named as a suspect in a criminal investigation by the authorities.


Miancha, baizhou, and nicotine solution.


According to reports, A had left work early the day before his death because he was feeling unwell. In a conversation with his wife, B, she informed him that the cause of his illness might have been the expired honey added to his breakfast tea. A was taken to the emergency room shortly after returning home and underwent simple tests and rest before being discharged. He then passed away the following day.


According to the prosecution and the police, it has been suggested that the amount of nicotine found in A's body and their dietary intake indicate that B fed A liquid nicotine three times. It has been reported that B gave A tea containing nicotine in the morning, rice soup containing nicotine when he returned home, and water mixed with liquid nicotine after A returned from the emergency room.


The wife stated that there was no reason to kill her husband.


B claims that "this is a medical accident, she did not kill her husband, and there was no reason for her to do so." The police presented evidence that B had purchased nicotine liquid from a nearby vape shop a few days before the incident. B initially stated that she had bought it for her husband who smoked. However, after investigating the people around A and her credit card usage, the police discovered that A quit smoking eight years ago. B then changed her story and claimed that she had bought the liquid for herself to smoke.


Furthermore, B claims that her husband, A, attempted suicide several months ago and that suicide-related search terms were found on his phone. During this same time, B was involved in a long-term extramarital affair with another man while also accumulating debts exceeding 100 million Korean won.


Most people in the area reported that A's husband also became aware of this fact and, as a result, the couple had a serious argument. The husband also has over 100 million Korean won in life insurance.


According to the judiciary department, the motive for B's murder, which included adultery and debt, was deemed sufficient.


The judiciary department believes that B has a criminal motive.


Firstly, B, the wife, revealed that she had conflicts with her husband in order to maintain a long-term relationship with her lover. If her husband were to die, it would solve her financial difficulties. Furthermore, information left behind by A indicated that he worked hard to support himself and his beloved son, in addition to his profession. There is no reason to believe that he would have made such an extreme choice, given the absence of a suicide note.


In the end, B was sentenced to 30 years in prison and is currently serving the sentence.


Disclaimer: 1. This article is compiled from third-party sources and is only intended for industry communication and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is only intended for industry communication and research purposes. 3. Due to the limited level of compilation, the compiled article may not express exactly the same meaning as the original. Please refer to the original article for accuracy. 4. 2FIRSTS maintains complete consistency with the Chinese government on any statement or position pertaining to domestic, Hong Kong, Macao, and Taiwan, as well as foreign issues. 5. The copyright for the compiled information belongs to the original media and the authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15